Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy
Crossref DOI link: https://doi.org/10.1038/bjc.2014.399
Published Online: 2014-07-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sasaki, H
Murakami, Y
Uemura, K
Sudo, T
Hashimoto, Y
Kondo, N
Sueda, T
License valid from 2014-07-17
Article History
Revised: 9 May 2014
Accepted: 24 June 2014
First Online: 17 July 2014
Competing interests
: The authors declare no conflict of interest.